Company intelligence / Profile preview

Razan Medical Trading

United Arab Emirates

Ownership: Private
Development stage: Other

Overview

Razan Medical Trading acts as a local UAE and regional distributor for innovative medical devices, including commercial launch of the revyve™ Antimicrobial Wound Gel (from Kane Biotech) and the HidraWear adhesive-free wound dressing (from Hidramed Solutions). These products are clinically proven for wound healing and exudate management.

Therapeutic areas: EndocrinologyDermatology
Modalities: DeviceWound care productWearable dressing
Industry: Consumable Medical Devices

Partnerships

Kane Biotech (distribution partner for revyve™ Wound Gel in UAE)Hidramed Solutions (distribution partner for HidraWear products in UAE)

Beyond the preview

Go deeper on Razan Medical Trading.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Razan Medical Trading.

Explore the full profile